POC

Now in its thirteenth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the global POC diagnostics market with updated insights and forecasts through 2030.

Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition delivers a comprehensive, forward-looking evaluation of one of the most strategically important segments of the in vitro diagnostics (IVD) industry.…

Immunoassays remain a foundational pillar of the in vitro diagnostics (IVD) landscape, underpinning a broad range of clinical testing applications despite the maturity of many platforms. Their continued relevance reflects both their versatility across disease areas and the steady pace of technological refinement that has sustained growth and clinical adoption over time. This Kalorama Information…

The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.

The global market for respiratory and non-respiratory IVD panel-based testing is undergoing continued structural evolution. Panel-based tests allow for the simultaneous detection of multiple pathogens and or resistance markers from a single specimen, supporting efficient workflows, faster time to results, and greater diagnostic confidence. Market growth is increasingly driven by broader clinical adoption and expanding…

In Vitro Diagnostics (IVD) in the United States, 6th Edition provides a comprehensive analysis of the largest and most influential IVD market in the world. This report is an essential resource for companies, manufacturers, executives, marketers, and other key stakeholders seeking actionable insights into the U.S. IVD industry—a market that serves as a global incubator…

The global in vitro diagnostics (IVD) market continues to expand in 2025, driven by powerful innovations in next-generation sequencing (NGS), microfluidics, and precision medicine that are transforming diagnostics into a more personalized, patient-centric field. IVD Test Procedure Volumes, 7th Edition (2025-2030) provides a comprehensive, data-driven analysis of global test volume trends, serving as a critical…

Kalorama Information’s Point-of-Care (POC) Urinalysis and Urinalysis Drugs of Abuse Testing Market, 2025 provides an in-depth analysis of the global market for point-of-care urinalysis and drugs of abuse testing. The report examines current market dynamics, technological trends, and future growth potential, with revenue forecasts through 2029.

Point-of-care testing encompasses diagnostic procedures performed near the patient,…

Kalorama Information’s Women’s Health Diagnostic Markets: Global Outlook and Forecast to 2030 offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women’s health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift—with women living longer than men—healthcare systems are under increasing pressure to recognize and address…

Kalorama Information’s new report, Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025, provides an in-depth analysis of one of the most pivotal segments of the in vitro diagnostics (IVD) industry with market estimates and forecasts spanning 2024-2029. Immunoassays—diagnostic tests that detect target analytes via antibody-antigen interactions—are foundational tools in clinical laboratories and point-of-care (POC) settings, enabling…

Now in its twelfth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the POC market from a global perspective with a five-year forecast.

Worldwide Market for Point-of-Care…

The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.

The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product…